0
2022
Percutaneous Transluminal Coronary Angioplasty (ptca) Balloon Catheters Market

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market

by Product (Normal balloon catheter, Drug eluting balloon catheter, Cutting balloon catheter, Scoring balloon catheter), by Delivery Platform (Rapid Exchange (RX) / Monorail balloon catheter, Over-the-wire (OTW) balloon catheter), by Compliance (Semi-Compliant, Non-Compliant), by Balloon Material (Polyolefin copolymer (POC), Polyethylene (PE), Polyethylene terephthalate (PET)): Global Opportunity Analysis and Industry Forecast, 2021-2031

✷  Report Code: A02303
May 2022 | Pages: 210
Tables: 174
Charts: 62
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market Research, 2031

The global percutaneous transluminal coronary angioplasty (ptca) balloon catheters market was valued at $1.2 billion in 2021, and is projected to reach $1.8 billion by 2031, growing at a CAGR of 4.4% from 2022 to 2031.

A minimally invasive treatment known as PTCA is used to unblock blocked or restricted coronary arteries caused due to coronary artery disease (CAD). PTCA balloon catheters allow blood to flow freely from the arteries to the heart muscles without the need of open-heart surgery. Smoking, high blood pressure, diabetes, and high cholesterol level in the blood all contribute to coronary heart disease. Chest pain, sweating, difficulty in breathing, dyspnea, and severe fatigue are some of the signs of coronary heart disease. Some of the primary factors driving the PTCA Balloon Catheters Market growth are geriatric population, technological improvements, and introduction of innovative products.

The pandemic of COVID-19 had a negative impact on market growth. During the COVID-19 pandemic, there was a decline in the frequency of emergency and general visits linked to cardiovascular disorders, which influenced product acceptance to some extent. Several data reveal that the frequency of elective cardiac, neurology, and urology surgeries for the management of certain chronic diseases has decreased since the social distancing standards and new operating protocols at healthcare facilities were effective in early 2021. Hence, overall COVID had a negative impact on the market.

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market, Percutaneous Transluminal Coronary Angioplasty Balloon Catheters Market, PTCA Balloon Catheters Market, PTCA Balloon Catheters Market size, PTCA Balloon Catheters Market share, PTCA Balloon Catheters Market trends, PTCA Balloon Catheters Market growth, PTCA Balloon Catheters Market analysis, PTCA Balloon Catheters Market forecast, PTCA Balloon Catheters Market opportunity

Get more information on this report : Request Sample Pages

The drivers of percutaneous transluminal coronary angioplasty balloon catheters market include its simplicity to use, safety, and cost-effective. Guiding catheters are used to show when interventional devices are being delivered to the peripheral or coronary vascular systems. The fundamental benefit of PTCA is that it eliminates the immediate post-operative discomforts associated with coronary bypass surgery while lowering morbidity. The global PTCA balloon catheter market is being driven by increase in geriatric population and surge in the occurrence of cardiovascular disease. The geriatric population is expected to fuel the expansion of the PTCA balloon catheters market, owing to the risk of cardiovascular problems that increase with age. High cholesterol levels in the blood, smoking, obesity, high blood pressure, and other variables linked with the risk of developing heart disease fuel the expansion of the PTCA balloon catheters market. However, as policies and standards are developed to ensure the safety of patients, the number of procedures will continue to rise. Revisions to national and international standards have been issued to assure the utmost safety of patients and healthcare workers, as well as to eliminate delays in chronic illness management care. Despite lower patient admissions in 2021, the market is expected to grow in the next years, due to a decrease in COVID-19 cases and a large proportion of the population suffering from chronic diseases.

The World Health Organization (WHO) on January 30, 2021 declared COVID-19 as pandemic. Coronavirus has impacted around 210 countries across the globe. State run administrations across the globe declared inescapable lockdowns as well as friendly distancing measures to forestall breakdown of the healthcare structure. States have additionally given constraints and preventions on undertakings and elective surgeries. These obstructions continue to influence the growth of different industries, and the quick effect of the episode changes starting with one industry then onto the following. The scattering, production, and store network have been impacted, because of the execution of lockdown across the globe.

The pandemic of COVID-19 had a negative impact on market growth. During the COVID-19 pandemic, there was a decline in the frequency of emergency and general visits linked to cardiovascular disorders, which influenced product acceptance to some extent. Several data reveal that the frequency of elective cardiac, neurology, and urology surgeries for the management of certain chronic diseases has decreased since the social distancing standards and new operating protocols at healthcare facilities were effective in early 2021. Hence, overall COVID had a negative impact on the market.

The percutaneous transluminal coronary angioplasty (ptca) balloon catheters market is segmented into Product, Delivery Platform, Compliance and Balloon Material.

The global PTCA balloon catheter market is segmented on the basis of product, , delivery platform, compliance, balloon material. On the basis of product , it is segmented into normal balloon catheter, drug eluting balloon catheter, cutting balloon catheter, and scoring balloon catheter. Depending on delivery platform, itis fragmented into over-the wire and rapid exchange/monorail balloon catheters. According to compliance, it is categorized into semi-compliant and non-compliant. As per balloon material, it is classified into polyolefin copolymer (POC), polyethylene (PE) and polyethylene terephthalate (PET) Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market

Segment review, by Product

Based on product, in PTCA balloon catheters market trends normal balloon catheter is projected to record a 4.5% CAGR and reach $1125.56 million by the end of the PTCA Balloon Catheters Market forecast period and the growth in the drug eluting balloon catheter segment is readjusted to a revised 5.3% CAGR for the next 10-year period.

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market

Segment review, by Delivery Platform

On the basis of delivery platform, in PTCA balloon catheters market analysis Rapid exchange balloon catheters that have guidewire along a short section which helps in saving time has been reported as the largest segment with a revenue of 1,080.9 million in 2021. Whereas, over-the wire balloon catheters feature guidewire that tracks along the full length of catheter with a CAGR of 7.1% in PTCA balloon catheters market share during the forecast period.

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market

Segment review, by compliance type

Based on compliance the PTCA balloon catheters market size is categorized into semi-compliant and non-compliant. The non –compliant balloons are made of polyester or nylon. They are used in applications where balloon needs to expand to a specific diameter and exert high pressure. The compliant balloons are made of polyurethane and silicone. They are able to stretch from 100% to 800% which makes them compatible to occlude the anatomy.

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market

Segment review, by Balloon Material

Based on balloon material, the PTCA balloon catheters industry is fragmented into polyolefin copolymer (POC), polyethylene (PE) and polyethylene terephthalate (PET). The Polyolefin copolymer (POC) segment dominated the market with a revenue of $672.35 million and is accounted to be the largest segment in 2021 and Polyethylene (PE) is accounted to be the fastest growing segment with a CAGR of 5.3% in the given forecast period.

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market

Region type segment review

Region wise,  North America has the largest market for PTCA balloon catheters. The PTCA balloon catheter market in North America is followed by Europe.

Due to rise in occurrences of coronary heart disease, rise in disposable income, increase in knowledge of heart diseases and associated treatments, and better healthcare infrastructure in Asia, the PTCA balloon catheter market is expected to grow rapidly in the  Asia pacific in  future.

The list of key players profiled in this report include Abbott Laboratories, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc., Medtronic plc., MicroPort Scientific Corporation, Terumo Corporation, and THE SPECTRANETICS CORPORATION.

Key players in the value chain include Lepu Medical Technology (Beijing) Co., Ltd., Meril Life Sciences Pvt. Ltd., and COOK MEDICAL INC.

Key Benefits For Stakeholders

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market Report Highlights

Aspects Details
By Product
  • Normal balloon catheter
  • Drug eluting balloon catheter
  • Cutting balloon catheter
  • Scoring balloon catheter
By Delivery Platform
  • Rapid Exchange (RX) / Monorail balloon catheter
  • Over-the-wire (OTW) balloon catheter
By Compliance
  • Semi-Compliant
  • Non-Compliant
By Balloon Material
  • Polyolefin copolymer (POC)
  • Polyethylene (PE)
  • Polyethylene terephthalate (PET)
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players ABOTT LABORATORIES, KONINKLIJKE PHILLIPS, ALVI MEDICA, BOSTON SCIENTIFIC CORPORATION, MEDTRONIC PLC, RONSTIS, B.BRAUN MELSUNGEN AG, IVASCULAR, BECTON, DICKINSON & COMPANY, BALTON SP ZOO
 
  • CHAPTER 1:INTRODUCTION

    • 1.1.Report description

    • 1.2.Key market segments

    • 1.3.Key benefits to the stakeholders

    • 1.4.Research Methodology

      • 1.4.1.Secondary research

      • 1.4.2.Primary research

      • 1.4.3.Analyst tools and models

  • CHAPTER 2:EXECUTIVE SUMMARY

    • 2.1.Key findings of the study

    • 2.2.CXO Perspective

  • CHAPTER 3:MARKET OVERVIEW

    • 3.1.Market definition and scope

    • 3.2.Key findings

      • 3.2.1.Top investment pockets

    • 3.3.Porter’s five forces analysis

    • 3.4.Top player positioning

    • 3.5.Market dynamics

      • 3.5.1.Drivers

      • 3.5.2.Restraints

      • 3.5.3.Opportunities

    • 3.6.COVID-19 Impact Analysis on the market

  • CHAPTER 4: PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY PRODUCT

    • 4.1 Overview

      • 4.1.1 Market size and forecast

    • 4.2 Normal balloon catheter

      • 4.2.1 Key market trends, growth factors and opportunities

      • 4.2.2 Market size and forecast, by region

      • 4.2.3 Market analysis by country

    • 4.3 Drug eluting balloon catheter

      • 4.3.1 Key market trends, growth factors and opportunities

      • 4.3.2 Market size and forecast, by region

      • 4.3.3 Market analysis by country

    • 4.4 Cutting balloon catheter

      • 4.4.1 Key market trends, growth factors and opportunities

      • 4.4.2 Market size and forecast, by region

      • 4.4.3 Market analysis by country

    • 4.5 Scoring balloon catheter

      • 4.5.1 Key market trends, growth factors and opportunities

      • 4.5.2 Market size and forecast, by region

      • 4.5.3 Market analysis by country

  • CHAPTER 5: PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM

    • 5.1 Overview

      • 5.1.1 Market size and forecast

    • 5.2 Rapid Exchange (RX) / Monorail balloon catheter

      • 5.2.1 Key market trends, growth factors and opportunities

      • 5.2.2 Market size and forecast, by region

      • 5.2.3 Market analysis by country

    • 5.3 Over-the-wire (OTW) balloon catheter

      • 5.3.1 Key market trends, growth factors and opportunities

      • 5.3.2 Market size and forecast, by region

      • 5.3.3 Market analysis by country

  • CHAPTER 6: PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COMPLIANCE

    • 6.1 Overview

      • 6.1.1 Market size and forecast

    • 6.2 Semi-Compliant

      • 6.2.1 Key market trends, growth factors and opportunities

      • 6.2.2 Market size and forecast, by region

      • 6.2.3 Market analysis by country

    • 6.3 Non-Compliant

      • 6.3.1 Key market trends, growth factors and opportunities

      • 6.3.2 Market size and forecast, by region

      • 6.3.3 Market analysis by country

  • CHAPTER 7: PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY BALLOON MATERIAL

    • 7.1 Overview

      • 7.1.1 Market size and forecast

    • 7.2 Polyolefin copolymer (POC)

      • 7.2.1 Key market trends, growth factors and opportunities

      • 7.2.2 Market size and forecast, by region

      • 7.2.3 Market analysis by country

    • 7.3 Polyethylene (PE)

      • 7.3.1 Key market trends, growth factors and opportunities

      • 7.3.2 Market size and forecast, by region

      • 7.3.3 Market analysis by country

    • 7.4 Polyethylene terephthalate (PET)

      • 7.4.1 Key market trends, growth factors and opportunities

      • 7.4.2 Market size and forecast, by region

      • 7.4.3 Market analysis by country

  • CHAPTER 8: PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY REGION

    • 8.1 Overview

      • 8.1.1 Market size and forecast

    • 8.2 North America

      • 8.2.1 Key trends and opportunities

      • 8.2.2 North America Market size and forecast, by Product

      • 8.2.3 North America Market size and forecast, by Delivery Platform

      • 8.2.4 North America Market size and forecast, by Compliance

      • 8.2.5 North America Market size and forecast, by Balloon Material

      • 8.2.6 North America Market size and forecast, by country

        • 8.2.6.1 U.S.
          • 8.2.6.1.1 Market size and forecast, by Product
          • 8.2.6.1.2 Market size and forecast, by Delivery Platform
          • 8.2.6.1.3 Market size and forecast, by Compliance
          • 8.2.6.1.4 Market size and forecast, by Balloon Material
        • 8.2.6.2 Canada
          • 8.2.6.2.1 Market size and forecast, by Product
          • 8.2.6.2.2 Market size and forecast, by Delivery Platform
          • 8.2.6.2.3 Market size and forecast, by Compliance
          • 8.2.6.2.4 Market size and forecast, by Balloon Material
        • 8.2.6.3 Mexico
          • 8.2.6.3.1 Market size and forecast, by Product
          • 8.2.6.3.2 Market size and forecast, by Delivery Platform
          • 8.2.6.3.3 Market size and forecast, by Compliance
          • 8.2.6.3.4 Market size and forecast, by Balloon Material
    • 8.3 Europe

      • 8.3.1 Key trends and opportunities

      • 8.3.2 Europe Market size and forecast, by Product

      • 8.3.3 Europe Market size and forecast, by Delivery Platform

      • 8.3.4 Europe Market size and forecast, by Compliance

      • 8.3.5 Europe Market size and forecast, by Balloon Material

      • 8.3.6 Europe Market size and forecast, by country

        • 8.3.6.1 Germany
          • 8.3.6.1.1 Market size and forecast, by Product
          • 8.3.6.1.2 Market size and forecast, by Delivery Platform
          • 8.3.6.1.3 Market size and forecast, by Compliance
          • 8.3.6.1.4 Market size and forecast, by Balloon Material
        • 8.3.6.2 France
          • 8.3.6.2.1 Market size and forecast, by Product
          • 8.3.6.2.2 Market size and forecast, by Delivery Platform
          • 8.3.6.2.3 Market size and forecast, by Compliance
          • 8.3.6.2.4 Market size and forecast, by Balloon Material
        • 8.3.6.3 U.K.
          • 8.3.6.3.1 Market size and forecast, by Product
          • 8.3.6.3.2 Market size and forecast, by Delivery Platform
          • 8.3.6.3.3 Market size and forecast, by Compliance
          • 8.3.6.3.4 Market size and forecast, by Balloon Material
        • 8.3.6.4 Italy
          • 8.3.6.4.1 Market size and forecast, by Product
          • 8.3.6.4.2 Market size and forecast, by Delivery Platform
          • 8.3.6.4.3 Market size and forecast, by Compliance
          • 8.3.6.4.4 Market size and forecast, by Balloon Material
        • 8.3.6.5 Spain
          • 8.3.6.5.1 Market size and forecast, by Product
          • 8.3.6.5.2 Market size and forecast, by Delivery Platform
          • 8.3.6.5.3 Market size and forecast, by Compliance
          • 8.3.6.5.4 Market size and forecast, by Balloon Material
        • 8.3.6.6 Rest of Europe
          • 8.3.6.6.1 Market size and forecast, by Product
          • 8.3.6.6.2 Market size and forecast, by Delivery Platform
          • 8.3.6.6.3 Market size and forecast, by Compliance
          • 8.3.6.6.4 Market size and forecast, by Balloon Material
    • 8.4 Asia-Pacific

      • 8.4.1 Key trends and opportunities

      • 8.4.2 Asia-Pacific Market size and forecast, by Product

      • 8.4.3 Asia-Pacific Market size and forecast, by Delivery Platform

      • 8.4.4 Asia-Pacific Market size and forecast, by Compliance

      • 8.4.5 Asia-Pacific Market size and forecast, by Balloon Material

      • 8.4.6 Asia-Pacific Market size and forecast, by country

        • 8.4.6.1 Japan
          • 8.4.6.1.1 Market size and forecast, by Product
          • 8.4.6.1.2 Market size and forecast, by Delivery Platform
          • 8.4.6.1.3 Market size and forecast, by Compliance
          • 8.4.6.1.4 Market size and forecast, by Balloon Material
        • 8.4.6.2 China
          • 8.4.6.2.1 Market size and forecast, by Product
          • 8.4.6.2.2 Market size and forecast, by Delivery Platform
          • 8.4.6.2.3 Market size and forecast, by Compliance
          • 8.4.6.2.4 Market size and forecast, by Balloon Material
        • 8.4.6.3 Australia
          • 8.4.6.3.1 Market size and forecast, by Product
          • 8.4.6.3.2 Market size and forecast, by Delivery Platform
          • 8.4.6.3.3 Market size and forecast, by Compliance
          • 8.4.6.3.4 Market size and forecast, by Balloon Material
        • 8.4.6.4 India
          • 8.4.6.4.1 Market size and forecast, by Product
          • 8.4.6.4.2 Market size and forecast, by Delivery Platform
          • 8.4.6.4.3 Market size and forecast, by Compliance
          • 8.4.6.4.4 Market size and forecast, by Balloon Material
        • 8.4.6.5 South Korea
          • 8.4.6.5.1 Market size and forecast, by Product
          • 8.4.6.5.2 Market size and forecast, by Delivery Platform
          • 8.4.6.5.3 Market size and forecast, by Compliance
          • 8.4.6.5.4 Market size and forecast, by Balloon Material
        • 8.4.6.6 Rest of Asia-Pacific
          • 8.4.6.6.1 Market size and forecast, by Product
          • 8.4.6.6.2 Market size and forecast, by Delivery Platform
          • 8.4.6.6.3 Market size and forecast, by Compliance
          • 8.4.6.6.4 Market size and forecast, by Balloon Material
    • 8.5 LAMEA

      • 8.5.1 Key trends and opportunities

      • 8.5.2 LAMEA Market size and forecast, by Product

      • 8.5.3 LAMEA Market size and forecast, by Delivery Platform

      • 8.5.4 LAMEA Market size and forecast, by Compliance

      • 8.5.5 LAMEA Market size and forecast, by Balloon Material

      • 8.5.6 LAMEA Market size and forecast, by country

        • 8.5.6.1 Brazil
          • 8.5.6.1.1 Market size and forecast, by Product
          • 8.5.6.1.2 Market size and forecast, by Delivery Platform
          • 8.5.6.1.3 Market size and forecast, by Compliance
          • 8.5.6.1.4 Market size and forecast, by Balloon Material
        • 8.5.6.2 Saudi Arabia
          • 8.5.6.2.1 Market size and forecast, by Product
          • 8.5.6.2.2 Market size and forecast, by Delivery Platform
          • 8.5.6.2.3 Market size and forecast, by Compliance
          • 8.5.6.2.4 Market size and forecast, by Balloon Material
        • 8.5.6.3 South Africa
          • 8.5.6.3.1 Market size and forecast, by Product
          • 8.5.6.3.2 Market size and forecast, by Delivery Platform
          • 8.5.6.3.3 Market size and forecast, by Compliance
          • 8.5.6.3.4 Market size and forecast, by Balloon Material
        • 8.5.6.4 Rest of LAMEA
          • 8.5.6.4.1 Market size and forecast, by Product
          • 8.5.6.4.2 Market size and forecast, by Delivery Platform
          • 8.5.6.4.3 Market size and forecast, by Compliance
          • 8.5.6.4.4 Market size and forecast, by Balloon Material
  • CHAPTER 9: COMPANY LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top winning strategies

    • 9.3. Product Mapping of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Key developments

  • CHAPTER 10: COMPANY PROFILES

    • 10.1 ALVI MEDICA

      • 10.1.1 Company overview

      • 10.1.2 Company snapshot

      • 10.1.3 Operating business segments

      • 10.1.4 Product portfolio

      • 10.1.5 Business performance

      • 10.1.6 Key strategic moves and developments

    • 10.2 ABOTT LABORATORIES

      • 10.2.1 Company overview

      • 10.2.2 Company snapshot

      • 10.2.3 Operating business segments

      • 10.2.4 Product portfolio

      • 10.2.5 Business performance

      • 10.2.6 Key strategic moves and developments

    • 10.3 BOSTON SCIENTIFIC CORPORATION

      • 10.3.1 Company overview

      • 10.3.2 Company snapshot

      • 10.3.3 Operating business segments

      • 10.3.4 Product portfolio

      • 10.3.5 Business performance

      • 10.3.6 Key strategic moves and developments

    • 10.4 BECTON, DICKINSON & COMPANY

      • 10.4.1 Company overview

      • 10.4.2 Company snapshot

      • 10.4.3 Operating business segments

      • 10.4.4 Product portfolio

      • 10.4.5 Business performance

      • 10.4.6 Key strategic moves and developments

    • 10.5 IVASCULAR

      • 10.5.1 Company overview

      • 10.5.2 Company snapshot

      • 10.5.3 Operating business segments

      • 10.5.4 Product portfolio

      • 10.5.5 Business performance

      • 10.5.6 Key strategic moves and developments

    • 10.6 RONSTIS

      • 10.6.1 Company overview

      • 10.6.2 Company snapshot

      • 10.6.3 Operating business segments

      • 10.6.4 Product portfolio

      • 10.6.5 Business performance

      • 10.6.6 Key strategic moves and developments

    • 10.7 KONINKLIJKE PHILLIPS

      • 10.7.1 Company overview

      • 10.7.2 Company snapshot

      • 10.7.3 Operating business segments

      • 10.7.4 Product portfolio

      • 10.7.5 Business performance

      • 10.7.6 Key strategic moves and developments

    • 10.8 MEDTRONIC PLC

      • 10.8.1 Company overview

      • 10.8.2 Company snapshot

      • 10.8.3 Operating business segments

      • 10.8.4 Product portfolio

      • 10.8.5 Business performance

      • 10.8.6 Key strategic moves and developments

    • 10.9 BALTON SP ZOO

      • 10.9.1 Company overview

      • 10.9.2 Company snapshot

      • 10.9.3 Operating business segments

      • 10.9.4 Product portfolio

      • 10.9.5 Business performance

      • 10.9.6 Key strategic moves and developments

    • 10.10 B.BRAUN MELSUNGEN AG

      • 10.10.1 Company overview

      • 10.10.2 Company snapshot

      • 10.10.3 Operating business segments

      • 10.10.4 Product portfolio

      • 10.10.5 Business performance

      • 10.10.6 Key strategic moves and developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY PRODUCT, 2021-2031,($MILLION)
    TABLE 2. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET REVENUE, FOR NORMAL BALLOON CATHETER, BY REGION , 2021-2031,($MILLION)
    TABLE 13. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET REVENUE, FOR OVER-THE-WIRE (OTW) BALLOON CATHETER, BY REGION , 2021-2031,($MILLION)
    TABLE 14. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET FOR OVER-THE-WIRE (OTW) BALLOON CATHETER BY COUNTRY, 2021-2031,($MILLION)
    TABLE 15. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COMPLIANCE, 2021-2031,($MILLION)
    TABLE 16. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET REVENUE, FOR SEMI-COMPLIANT, BY REGION , 2021-2031,($MILLION)
    TABLE 17. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET FOR SEMI-COMPLIANT BY COUNTRY, 2021-2031,($MILLION)
    TABLE 3. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET FOR NORMAL BALLOON CATHETER BY COUNTRY, 2021-2031,($MILLION)
    TABLE 4. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET REVENUE, FOR DRUG ELUTING BALLOON CATHETER, BY REGION , 2021-2031,($MILLION)
    TABLE 5. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET FOR DRUG ELUTING BALLOON CATHETER BY COUNTRY, 2021-2031,($MILLION)
    TABLE 6. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET REVENUE, FOR CUTTING BALLOON CATHETER, BY REGION , 2021-2031,($MILLION)
    TABLE 7. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET FOR CUTTING BALLOON CATHETER BY COUNTRY, 2021-2031,($MILLION)
    TABLE 8. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET REVENUE, FOR SCORING BALLOON CATHETER, BY REGION , 2021-2031,($MILLION)
    TABLE 9. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET FOR SCORING BALLOON CATHETER BY COUNTRY, 2021-2031,($MILLION)
    TABLE 10. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM, 2021-2031,($MILLION)
    TABLE 11. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET REVENUE, FOR RAPID EXCHANGE (RX) / MONORAIL BALLOON CATHETER, BY REGION , 2021-2031,($MILLION)
    TABLE 12. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET FOR RAPID EXCHANGE (RX) / MONORAIL BALLOON CATHETER BY COUNTRY, 2021-2031,($MILLION)
    TABLE 18. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET REVENUE, FOR NON-COMPLIANT, BY REGION , 2021-2031,($MILLION)
    TABLE 19. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET FOR NON-COMPLIANT BY COUNTRY, 2021-2031,($MILLION)
    TABLE 20. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY BALLOON MATERIAL, 2021-2031,($MILLION)
    TABLE 21. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET REVENUE, FOR POLYOLEFIN COPOLYMER (POC), BY REGION , 2021-2031,($MILLION)
    TABLE 22. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET FOR POLYOLEFIN COPOLYMER (POC) BY COUNTRY, 2021-2031,($MILLION)
    TABLE 23. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET REVENUE, FOR POLYETHYLENE (PE), BY REGION , 2021-2031,($MILLION)
    TABLE 24. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET FOR POLYETHYLENE (PE) BY COUNTRY, 2021-2031,($MILLION)
    TABLE 25. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET REVENUE, FOR POLYETHYLENE TEREPHTHALATE (PET), BY REGION , 2021-2031,($MILLION)
    TABLE 26. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET FOR POLYETHYLENE TEREPHTHALATE (PET) BY COUNTRY, 2021-2031,($MILLION)
    TABLE 27. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY REGION, 2021-2031,($MILLION)
    TABLE 28. NORTH AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY PRODUCT, 2021-2031,($MILLION)
    TABLE 29. NORTH AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM, 2021-2031,($MILLION)
    TABLE 30. NORTH AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COMPLIANCE, 2021-2031,($MILLION)
    TABLE 31. NORTH AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY BALLOON MATERIAL, 2021-2031,($MILLION)
    TABLE 32. NORTH AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COUNTRY, 2021-2031,($MILLION)
    TABLE 33. U.S. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY PRODUCT, 2021-2031,($MILLION)
    TABLE 34. U.S. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM, 2021-2031,($MILLION)
    TABLE 47. EUROPE PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COMPLIANCE, 2021-2031,($MILLION)
    TABLE 48. EUROPE PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY BALLOON MATERIAL, 2021-2031,($MILLION)
    TABLE 49. EUROPE PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COUNTRY, 2021-2031,($MILLION)
    TABLE 50. GERMANY PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY PRODUCT, 2021-2031,($MILLION)
    TABLE 35. U.S. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COMPLIANCE, 2021-2031,($MILLION)
    TABLE 36. U.S. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY BALLOON MATERIAL, 2021-2031,($MILLION)
    TABLE 37. CANADA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY PRODUCT, 2021-2031,($MILLION)
    TABLE 38. CANADA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM, 2021-2031,($MILLION)
    TABLE 39. CANADA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COMPLIANCE, 2021-2031,($MILLION)
    TABLE 40. CANADA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY BALLOON MATERIAL, 2021-2031,($MILLION)
    TABLE 41. MEXICO PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY PRODUCT, 2021-2031,($MILLION)
    TABLE 42. MEXICO PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM, 2021-2031,($MILLION)
    TABLE 43. MEXICO PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COMPLIANCE, 2021-2031,($MILLION)
    TABLE 44. MEXICO PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY BALLOON MATERIAL, 2021-2031,($MILLION)
    TABLE 45. EUROPE PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY PRODUCT, 2021-2031,($MILLION)
    TABLE 46. EUROPE PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM, 2021-2031,($MILLION)
    TABLE 51. GERMANY PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM, 2021-2031,($MILLION)
    TABLE 52. GERMANY PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COMPLIANCE, 2021-2031,($MILLION)
    TABLE 53. GERMANY PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY BALLOON MATERIAL, 2021-2031,($MILLION)
    TABLE 54. FRANCE PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY PRODUCT, 2021-2031,($MILLION)
    TABLE 55. FRANCE PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM, 2021-2031,($MILLION)
    TABLE 56. FRANCE PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COMPLIANCE, 2021-2031,($MILLION)
    TABLE 57. FRANCE PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY BALLOON MATERIAL, 2021-2031,($MILLION)
    TABLE 58. U.K. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY PRODUCT, 2021-2031,($MILLION)
    TABLE 59. U.K. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM, 2021-2031,($MILLION)
    TABLE 60. U.K. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COMPLIANCE, 2021-2031,($MILLION)
    TABLE 61. U.K. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY BALLOON MATERIAL, 2021-2031,($MILLION)
    TABLE 62. ITALY PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY PRODUCT, 2021-2031,($MILLION)
    TABLE 63. ITALY PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM, 2021-2031,($MILLION)
    TABLE 64. ITALY PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COMPLIANCE, 2021-2031,($MILLION)
    TABLE 65. ITALY PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY BALLOON MATERIAL, 2021-2031,($MILLION)
    TABLE 66. SPAIN PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY PRODUCT, 2021-2031,($MILLION)
    TABLE 67. SPAIN PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM, 2021-2031,($MILLION)
    TABLE 68. SPAIN PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COMPLIANCE, 2021-2031,($MILLION)
    TABLE 75. ASIA-PACIFIC PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM, 2021-2031,($MILLION)
    TABLE 76. ASIA-PACIFIC PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COMPLIANCE, 2021-2031,($MILLION)
    TABLE 77. ASIA-PACIFIC PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY BALLOON MATERIAL, 2021-2031,($MILLION)
    TABLE 78. ASIA-PACIFIC PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COUNTRY, 2021-2031,($MILLION)
    TABLE 79. JAPAN PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY PRODUCT, 2021-2031,($MILLION)
    TABLE 80. JAPAN PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM, 2021-2031,($MILLION)
    TABLE 81. JAPAN PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COMPLIANCE, 2021-2031,($MILLION)
    TABLE 82. JAPAN PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY BALLOON MATERIAL, 2021-2031,($MILLION)
    TABLE 69. SPAIN PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY BALLOON MATERIAL, 2021-2031,($MILLION)
    TABLE 70. REST OF EUROPE PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY PRODUCT, 2021-2031,($MILLION)
    TABLE 71. REST OF EUROPE PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM, 2021-2031,($MILLION)
    TABLE 72. REST OF EUROPE PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COMPLIANCE, 2021-2031,($MILLION)
    TABLE 73. REST OF EUROPE PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY BALLOON MATERIAL, 2021-2031,($MILLION)
    TABLE 74. ASIA-PACIFIC PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY PRODUCT, 2021-2031,($MILLION)
    TABLE 83. CHINA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY PRODUCT, 2021-2031,($MILLION)
    TABLE 84. CHINA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM, 2021-2031,($MILLION)
    TABLE 85. CHINA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COMPLIANCE, 2021-2031,($MILLION)
    TABLE 86. CHINA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY BALLOON MATERIAL, 2021-2031,($MILLION)
    TABLE 87. AUSTRALIA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY PRODUCT, 2021-2031,($MILLION)
    TABLE 88. AUSTRALIA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM, 2021-2031,($MILLION)
    TABLE 89. AUSTRALIA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COMPLIANCE, 2021-2031,($MILLION)
    TABLE 90. AUSTRALIA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY BALLOON MATERIAL, 2021-2031,($MILLION)
    TABLE 91. INDIA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY PRODUCT, 2021-2031,($MILLION)
    TABLE 92. INDIA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM, 2021-2031,($MILLION)
    TABLE 93. INDIA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COMPLIANCE, 2021-2031,($MILLION)
    TABLE 94. INDIA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY BALLOON MATERIAL, 2021-2031,($MILLION)
    TABLE 95. SOUTH KOREA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY PRODUCT, 2021-2031,($MILLION)
    TABLE 96. SOUTH KOREA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM, 2021-2031,($MILLION)
    TABLE 97. SOUTH KOREA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COMPLIANCE, 2021-2031,($MILLION)
    TABLE 98. SOUTH KOREA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY BALLOON MATERIAL, 2021-2031,($MILLION)
    TABLE 99. REST OF ASIA-PACIFIC PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY PRODUCT, 2021-2031,($MILLION)
    TABLE 100. REST OF ASIA-PACIFIC PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM, 2021-2031,($MILLION)
    TABLE 101. REST OF ASIA-PACIFIC PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COMPLIANCE, 2021-2031,($MILLION)
    TABLE 102. REST OF ASIA-PACIFIC PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY BALLOON MATERIAL, 2021-2031,($MILLION)
    TABLE 103. LAMEA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY PRODUCT, 2021-2031,($MILLION)
    TABLE 104. LAMEA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM, 2021-2031,($MILLION)
    TABLE 105. LAMEA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COMPLIANCE, 2021-2031,($MILLION)
    TABLE 106. LAMEA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY BALLOON MATERIAL, 2021-2031,($MILLION)
    TABLE 107. LAMEA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COUNTRY, 2021-2031,($MILLION)
    TABLE 108. BRAZIL PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY PRODUCT, 2021-2031,($MILLION)
    TABLE 109. BRAZIL PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM, 2021-2031,($MILLION)
    TABLE 110. BRAZIL PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COMPLIANCE, 2021-2031,($MILLION)
    TABLE 111. BRAZIL PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY BALLOON MATERIAL, 2021-2031,($MILLION)
    TABLE 112. SAUDI ARABIA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY PRODUCT, 2021-2031,($MILLION)
    TABLE 113. SAUDI ARABIA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM, 2021-2031,($MILLION)
    TABLE 114. SAUDI ARABIA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COMPLIANCE, 2021-2031,($MILLION)
    TABLE 115. SAUDI ARABIA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY BALLOON MATERIAL, 2021-2031,($MILLION)
    TABLE 116. SOUTH AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY PRODUCT, 2021-2031,($MILLION)
    TABLE 117. SOUTH AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM, 2021-2031,($MILLION)
    TABLE 118. SOUTH AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COMPLIANCE, 2021-2031,($MILLION)
    TABLE 119. SOUTH AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY BALLOON MATERIAL, 2021-2031,($MILLION)
    TABLE 120. REST OF LAMEA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY PRODUCT, 2021-2031,($MILLION)
    TABLE 121. REST OF LAMEA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM, 2021-2031,($MILLION)
    TABLE 122. REST OF LAMEA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COMPLIANCE, 2021-2031,($MILLION)
    TABLE 123. REST OF LAMEA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY BALLOON MATERIAL, 2021-2031,($MILLION)
    TABLE 124.ALVI MEDICA: COMPANY SNAPSHOT
    TABLE 125.ALVI MEDICA: OPERATING SEGMENTS
    TABLE 126.ALVI MEDICA: PRODUCT PORTFOLIO
    TABLE 127.ALVI MEDICA: NET SALES,
    TABLE 128.ALVI MEDICA: KEY STRATERGIES
    TABLE 129.ABOTT LABORATORIES: COMPANY SNAPSHOT
    TABLE 130.ABOTT LABORATORIES: OPERATING SEGMENTS
    TABLE 131.ABOTT LABORATORIES: PRODUCT PORTFOLIO
    TABLE 132.ABOTT LABORATORIES: NET SALES,
    TABLE 133.ABOTT LABORATORIES: KEY STRATERGIES
    TABLE 134.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
    TABLE 135.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
    TABLE 136.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
    TABLE 137.BOSTON SCIENTIFIC CORPORATION: NET SALES,
    TABLE 138.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
    TABLE 139.BECTON, DICKINSON & COMPANY: COMPANY SNAPSHOT
    TABLE 140.BECTON, DICKINSON & COMPANY: OPERATING SEGMENTS
    TABLE 141.BECTON, DICKINSON & COMPANY: PRODUCT PORTFOLIO
    TABLE 142.BECTON, DICKINSON & COMPANY: NET SALES,
    TABLE 143.BECTON, DICKINSON & COMPANY: KEY STRATERGIES
    TABLE 144.IVASCULAR: COMPANY SNAPSHOT
    TABLE 145.IVASCULAR: OPERATING SEGMENTS
    TABLE 146.IVASCULAR: PRODUCT PORTFOLIO
    TABLE 147.IVASCULAR: NET SALES,
    TABLE 148.IVASCULAR: KEY STRATERGIES
    TABLE 149.RONSTIS: COMPANY SNAPSHOT
    TABLE 150.RONSTIS: OPERATING SEGMENTS
    TABLE 151.RONSTIS: PRODUCT PORTFOLIO
    TABLE 152.RONSTIS: NET SALES,
    TABLE 153.RONSTIS: KEY STRATERGIES
    TABLE 154.KONINKLIJKE PHILLIPS: COMPANY SNAPSHOT
    TABLE 155.KONINKLIJKE PHILLIPS: OPERATING SEGMENTS
    TABLE 156.KONINKLIJKE PHILLIPS: PRODUCT PORTFOLIO
    TABLE 157.KONINKLIJKE PHILLIPS: NET SALES,
    TABLE 158.KONINKLIJKE PHILLIPS: KEY STRATERGIES
    TABLE 159.MEDTRONIC PLC: COMPANY SNAPSHOT
    TABLE 160.MEDTRONIC PLC: OPERATING SEGMENTS
    TABLE 161.MEDTRONIC PLC: PRODUCT PORTFOLIO
    TABLE 162.MEDTRONIC PLC: NET SALES,
    TABLE 163.MEDTRONIC PLC: KEY STRATERGIES
    TABLE 164.BALTON SP ZOO: COMPANY SNAPSHOT
    TABLE 165.BALTON SP ZOO: OPERATING SEGMENTS
    TABLE 166.BALTON SP ZOO: PRODUCT PORTFOLIO
    TABLE 167.BALTON SP ZOO: NET SALES,
    TABLE 168.BALTON SP ZOO: KEY STRATERGIES
    TABLE 169.B.BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
    TABLE 170.B.BRAUN MELSUNGEN AG: OPERATING SEGMENTS
    TABLE 171.B.BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
    TABLE 172.B.BRAUN MELSUNGEN AG: NET SALES,
    TABLE 173.B.BRAUN MELSUNGEN AG: KEY STRATERGIES
  • LIST OF FIGURES

  • FIGURE 1.PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET SEGMENTATION
    FIGURE 2.PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031
    FIGURE 3.PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031
    FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
    FIGURE 5.PORTER FIVE-1
    FIGURE 6.PORTER FIVE-2
    FIGURE 7.PORTER FIVE-3
    FIGURE 8.PORTER FIVE-4
    FIGURE 9.PORTER FIVE-5
    FIGURE 10.TOP PLAYER POSITIONING
    FIGURE 11.PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 12.PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,BY PRODUCT,2021(%)
    FIGURE 13.COMPARATIVE SHARE ANALYSIS OF NORMAL BALLOON CATHETER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031(%)
    FIGURE 14.COMPARATIVE SHARE ANALYSIS OF DRUG ELUTING BALLOON CATHETER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031(%)
    FIGURE 15.COMPARATIVE SHARE ANALYSIS OF CUTTING BALLOON CATHETER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031(%)
    FIGURE 16.COMPARATIVE SHARE ANALYSIS OF SCORING BALLOON CATHETER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031(%)
    FIGURE 17.PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,BY DELIVERY PLATFORM,2021(%)
    FIGURE 18.COMPARATIVE SHARE ANALYSIS OF RAPID EXCHANGE (RX) / MONORAIL BALLOON CATHETER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031(%)
    FIGURE 19.COMPARATIVE SHARE ANALYSIS OF OVER-THE-WIRE (OTW) BALLOON CATHETER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031(%)
    FIGURE 20.PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,BY COMPLIANCE,2021(%)
    FIGURE 21.COMPARATIVE SHARE ANALYSIS OF SEMI-COMPLIANT PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031(%)
    FIGURE 22.COMPARATIVE SHARE ANALYSIS OF NON-COMPLIANT PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031(%)
    FIGURE 23.PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,BY BALLOON MATERIAL,2021(%)
    FIGURE 24.COMPARATIVE SHARE ANALYSIS OF POLYOLEFIN COPOLYMER (POC) PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031(%)
    FIGURE 25.COMPARATIVE SHARE ANALYSIS OF POLYETHYLENE (PE) PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031(%)
    FIGURE 26.COMPARATIVE SHARE ANALYSIS OF POLYETHYLENE TEREPHTHALATE (PET) PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031(%)
    FIGURE 27.PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET BY REGION,2021
    FIGURE 28.U.S. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 29.CANADA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 30.MEXICO PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 31.GERMANY PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 32.FRANCE PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 33.U.K. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 34.ITALY PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 35.SPAIN PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 36.REST OF EUROPE PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 37.JAPAN PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 38.CHINA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 39.AUSTRALIA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 40.INDIA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 41.SOUTH KOREA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 42.REST OF ASIA-PACIFIC PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 43.BRAZIL PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 44.SAUDI ARABIA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 45.SOUTH AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 46.REST OF LAMEA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET,2021-2031($MILLION)
    FIGURE 47. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 48. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 49. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 50.PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 51.COMPETITIVE DASHBOARD
    FIGURE 52.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
    FIGURE 53.ALVI MEDICA.: NET SALES ,($MILLION)
    FIGURE 54.ABOTT LABORATORIES.: NET SALES ,($MILLION)
    FIGURE 55.BOSTON SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
    FIGURE 56.BECTON, DICKINSON & COMPANY.: NET SALES ,($MILLION)
    FIGURE 57.IVASCULAR.: NET SALES ,($MILLION)
    FIGURE 58.RONSTIS.: NET SALES ,($MILLION)
    FIGURE 59.KONINKLIJKE PHILLIPS.: NET SALES ,($MILLION)
    FIGURE 60.MEDTRONIC PLC.: NET SALES ,($MILLION)
    FIGURE 61.BALTON SP ZOO.: NET SALES ,($MILLION)
    FIGURE 62.B.BRAUN MELSUNGEN AG.: NET SALES ,($MILLION)

 
 

A minimally invasive treatment called percutaneous transluminal coronary angioplasty (PTCA) is performed to unblock blocked or constricted coronary arteries. PTCA balloons are inflated inside a clogged coronary artery, to open the blockage and allow easy blood flow. PTCA balloon catheters allow blood to flow freely from the arteries to the heart muscles without the need of open heart surgery.

Smoking, high blood pressure, diabetes, and high cholesterol level in the blood all contribute to coronary heart disease along with chest pain, sweating, difficulty in breathing, dyspnea, and severe fatigue are some of the signs of coronary heart disease. Some of the primary factors driving the PTCA Balloon Catheters Market growth of the PTCA balloon catheter market are an older population, technological improvements, and the introduction to innovative products.

One of the primary reasons driving market value is the expanding geriatric population, which is accompanied by an increase in the prevalence of aortic disease, venous thromboembolism (VTE), and peripheral arterial disease (PAD) due to age-related changes in vascular structure and function. The number of elderly individuals in Asia-Pacific is increasing at an unprecedented rate, and the region's ageing population has already reached critical mass.

In 2020, North America has the largest market for PTCA balloon catheters industry because of increased healthcare infrastructure, government initiatives, an increase in the rates of cardiac diseases, and rising healthcare expenditures in this region.

PURCHASE OPTIONS

$3,456

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The top companies include Abbott Laboratories, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc., Medtronic plc, MicroPort Scientific Corporation, Terumo Corporation, and THE SPECTRANETICS CORPORATION.

A. The leading application of Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market includes peripheral vascular diseases and cardiovascular disorders.

A. The trends include increase in ageing population and changes in lifestyle leading to hypertension, obesity, and other risk factors that lead to vascular disorders is expected to propel the growth of the PTCA balloon catheters market

A. The global percutaneous transluminal coronary angioplasty (PTCA) balloon catheters market was estimated to be $1,2021.23 million in 2021 and is estimated to reach $1,848.76 million in 2031 with an expected CAGR of 4.4% from 2021 to 2031.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample
RELATED TAGS

Purchase Full Report of
Percutaneous Transluminal Coronary Angioplasty (ptca) Balloon Catheters Market

Start reading instantly.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (May 2023 - May 2024)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (May 2023 - May 2024)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (May 2023 - May 2024)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (May 2023 - May 2024)
  • Enterprise
    License/PDF

  • $10,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (May 2023 - May 2024)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers